BRAIDWELL LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001920938

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2024 · 64 positions · Total reported value $2.55B · Top-10 concentration 37.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.0% · 24 new · 32 cut · 25 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.0% · vs SPY +9.2% · Prev Value $2.64B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2024 13F filing, BRAIDWELL LP disclosed 64 equity positions with a combined reported value of $2.55B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 37.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were NVCR ($134.50M), NBIX ($123.09M), XENE ($114.23M). By sector, the heaviest allocations are Health Care 84.4%, Industrials 2.6%. Versus the prior quarter, allocation shifted toward Industrials (+2.6pp) and away from Other (-0.7pp), Health Care (-1.9pp).

Versus the prior quarter, BRAIDWELL LP opened 24 new positions, trimmed 32 and fully exited 25, a turnover rate of 75.0% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q4 2024 were TMDX ($57.49M), TMO ($46.69M), GERN ($24.80M).

Of the 25 positions fully exited versus the prior quarter, the largest were TVTX ($53.54M), MDGL ($39.01M), ARVN ($31.64M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • TMDX TRANSMEDICS GROUP INC · $57.49M
  • TMO THERMO FISHER SCIENTIFIC INC · $46.69M
  • GERN GERON CORP · $24.80M
  • BRKR BRUKER CORP · $20.70M
  • NUVL NUVALENT INC · $18.88M
  • DYN DYNE THERAPEUTICS INC · $16.05M
  • CADL CANDEL THERAPEUTICS INC · $13.89M
  • RCUS ARCUS BIOSCIENCES INC · $11.94M

Fully Exited (vs previous quarter)

  • TVTX TRAVERE THERAPEUTICS INC · prev qtr: $53.54M
  • MDGL MADRIGAL PHARMACEUTICALS INC · prev qtr: $39.01M
  • ARVN ARVINAS INC · prev qtr: $31.64M
  • RLAY RELAY THERAPEUTICS INC COM · prev qtr: $24.78M
  • OCUL OCULAR THERAPEUTIX INC · prev qtr: $19.49M
  • BSX BOSTON SCIENTIFIC CORP · prev qtr: $15.85M · history
  • HAE HAEMONETICS CORP MASS · prev qtr: $10.64M
  • ALEC ALECTOR INC COM · prev qtr: $10.06M

Insider Transactions (Form 4)

Latest BRAIDWELL LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Braidwell LP, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 83 positions worth $2.54B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-122966 (status: Approved), registered 2022-01-03
  • Regulatory AUM (Form ADV): $3.63B as of 2026-09-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 11 hedge funds
  • Website: braidwell.com

Portfolio Structure

  • 83 positions · $2.54B reported value (Q2 2026)
  • Top 10 holdings = 32.8% of reported value
  • Largest position: CAI (CARIS LIFE SCIENCES INC) at 5.8%
  • Average position size: $30.62M

Sector Tilt

  • Health Care 90.1%
  • Information Technology 4.3%
  • Industrials 4.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 24 new, 21 added, 32 reduced, 25 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 84.4%
Other 12.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 140.83M $134.50M 5.27%
5.27%
Hold
2 901.79K $123.09M 4.83%
4.83%
Reduce
3 2.91M $114.23M 4.48%
4.48%
Add
4 116.38M $98.27M 3.85%
3.85%
Hold
5 2.98M $96.90M 3.80%
3.80%
Add
6 3.28M $94.17M 3.69%
3.69%
Add
7 2.85M $87.00M 3.41%
3.41%
Reduce
8 375.18K $78.23M 3.07%
3.07%
Add
9 1.54M $69.78M 2.73%
2.73%
Reduce
10 3.45M $68.29M 2.68%
2.68%
Add
11 2.10M $66.97M 2.62%
2.62%
Reduce
12 705.39K $63.61M 2.49%
2.49%
Reduce
13 2.33M $62.27M 2.44%
2.44%
Add
14 4.87M $61.75M 2.42%
2.42%
Hold
15 2.58M $60.03M 2.35%
2.35%
Add
16 1.48M $59.54M 2.33%
2.33%
Add
17 922.10K $57.49M 2.25%
2.25%
New
18 293.41K $54.39M 2.13%
2.13%
Add
19 80.77K $49.67M 1.95%
1.95%
Reduce
20 89.75K $46.69M 1.83%
1.83%
New
21 53.59M $45.98M 1.80%
1.80%
Add
22 8.35M $45.53M 1.78%
1.78%
Hold
23 364.90K $44.37M 1.74%
1.74%
Reduce
24 183.83K $43.66M 1.71%
1.71%
Reduce
25 288.88K $43.31M 1.70%
1.70%
Reduce
26 4.11M $43.15M 1.69%
1.69%
Add
27 283.82K $40.85M 1.60%
1.60%
Reduce
28 3.83M $39.61M 1.55%
1.55%
Reduce
29 75.30K $39.30M 1.54%
1.54%
Reduce
30 4.26M $39.07M 1.53%
1.53%
Add
31 309.87K $35.31M 1.38%
1.38%
Add
32 2.00M $34.85M 1.37%
1.37%
Add
33 200.50K $31.41M 1.23%
1.23%
Add
34 907.04K $30.43M 1.19%
1.19%
Add
35 1.89M $29.99M 1.18%
1.18%
Add
36 1.15M $27.10M 1.06%
1.06%
Add
37 1.21M $26.30M 1.03%
1.03%
Add
38 1.11M $25.68M 1.01%
1.01%
Hold
39 3.50M $24.91M 0.98%
0.98%
Add
40 7.01M $24.80M 0.97%
0.97%
New
41 5.44M $24.10M 0.94%
0.94%
Add
42 353.20K $20.70M 0.81%
0.81%
New
43 353.00K $19.84M 0.78%
0.78%
Add
44 241.24K $18.88M 0.74%
0.74%
New
45 222.42K $18.21M 0.71%
0.71%
Reduce
46 1.48M $17.89M 0.70%
0.70%
Reduce
47 18.50M $17.87M 0.70%
0.70%
Add
48 17.40M $16.28M 0.64%
0.64%
Reduce
49 681.18K $16.05M 0.63%
0.63%
New
50 714.66K $15.28M 0.60%
0.60%
Add

FAQ

What did BRAIDWELL LP buy in 2024-Q4?

In its 2024-Q4 13F filing, BRAIDWELL LP reported 64 equity positions worth $2.55B in aggregate; its largest disclosed positions were NVCR ($134.50M), NBIX ($123.09M), XENE ($114.23M).

How large is BRAIDWELL LP's portfolio?

BRAIDWELL LP reported $2.55B of long equity holdings across 64 positions as of 2024-Q4. Top-10 holdings account for 37.8% of reported value.

What is BRAIDWELL LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/braidwell/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →